Legal remedies for medical ghostwriting: imposing fraud liability on guest authors of ghostwritten articles.
作者信息
Stern Simon, Lemmens Trudo
机构信息
Faculty of Law, University of Toronto, Toronto, Ontario, Canada.
出版信息
PLoS Med. 2010 Aug;8(8):e1001070. doi: 10.1371/journal.pmed.1001070. Epub 2011 Aug 2.
Abstract
摘要
相似文献
1
Legal remedies for medical ghostwriting: imposing fraud liability on guest authors of ghostwritten articles.医学代笔的法律补救措施：对代笔文章的客座作者施加欺诈责任。
PLoS Med. 2010 Aug;8(8):e1001070. doi: 10.1371/journal.pmed.1001070. Epub 2011 Aug 2.
2
Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation.与罗非昔布相关出版物中的客座作者身份和代笔行为：以罗非昔布诉讼中的行业文件为例
JAMA. 2008 Apr 16;299(15):1800-12. doi: 10.1001/jama.299.15.1800.
3
Challenging medical ghostwriting in US courts.在美国法庭上挑战医疗 ghostwriting。
PLoS Med. 2012 Jan;9(1):e1001163. doi: 10.1371/journal.pmed.1001163. Epub 2012 Jan 24.
4
Legal and ethical aspects of ghostwriting in medicine.医学领域代笔的法律和伦理问题。
Arch Immunol Ther Exp (Warsz). 2011 Feb;59(1):1-9. doi: 10.1007/s00005-010-0105-y. Epub 2011 Jan 14.
5
Ghost marketing: pharmaceutical companies and ghostwritten journal articles.幽灵营销：制药公司与代笔期刊文章
Perspect Biol Med. 2007 Winter;50(1):18-31. doi: 10.1353/pbm.2007.0009.
6
Medical ghostwriting and informed consent.医学代笔与知情同意
Bioethics. 2014 Nov;28(9):491-9. doi: 10.1111/bioe.12017. Epub 2013 Feb 28.
7
Haunted manuscripts: ghost authorship in the medical literature.闹鬼的手稿：医学文献中的幽灵作者现象
Account Res. 2005 Apr-Jun;12(2):103-14. doi: 10.1080/08989620590957175.
8
Integrity of Authorship and Peer Review Practices: Challenges and Opportunities for Improvement.作者诚信和同行评审实践：改进的挑战和机遇。
J Korean Med Sci. 2018 Oct 18;33(46):e287. doi: 10.3346/jkms.2018.33.e287. eCollection 2018 Nov 12.
9
Industry-sponsored ghostwriting in clinical trial reporting: a case study.临床试验报告中行业资助的代笔行为：一项案例研究。
Account Res. 2008 Jul-Sep;15(3):152-67. doi: 10.1080/08989620802194384.
10
The involvement of professional medical writers in medical publications: results of a Delphi study.专业医学撰写人员在医学出版物中的参与情况：一项德尔菲研究的结果
Curr Med Res Opin. 2005 Feb;21(2):311-6. doi: 10.1185/030079905x25569.
引用本文的文献
1
Off-Label Use vs Off-Label Marketing: Part 2: Off-Label Marketing-Consequences for Patients, Clinicians, and Researchers.药品未按批准用途使用与药品未按批准用途营销：第2部分：药品未按批准用途营销对患者、临床医生和研究人员的影响
JACC Basic Transl Sci. 2023 Mar 27;8(3):359-370. doi: 10.1016/j.jacbts.2022.12.012. eCollection 2023 Mar.
2
Clinician Liability in Prescribing Antidepressants.临床医生在开具抗抑郁药方面的责任。
Focus (Am Psychiatr Publ). 2019 Oct;17(4):372-379. doi: 10.1176/appi.focus.20190024. Epub 2019 Nov 6.
3
Fake Peer Review and Inappropriate Authorship Are Real Evils.虚假同行评审和不当署名是真正的祸害。
J Korean Med Sci. 2018 Dec 26;34(2):e6. doi: 10.3346/jkms.2019.34.e6. eCollection 2019 Jan 14.
4
Industry Collaboration and Primary Guest Authorship of High-Impact Randomized Clinical Trials: A Cross-Sectional Study.行业合作与高影响力随机临床试验的第一作者身份：一项横断面研究
J Gen Intern Med. 2015 Oct;30(10):1421-5. doi: 10.1007/s11606-015-3299-1. Epub 2015 Apr 2.
5
Ethics and Scientific Integrity in Public Health, Epidemiological and Clinical Research.公共卫生、流行病学和临床研究中的伦理与科学诚信。
Public Health Rev. 2012 Jan 1;34(1):71-83. doi: 10.1007/BF03391657.
6
How basic scientists help the pharmaceutical industry market drugs.基础科学家如何帮助制药行业推广药物。
PLoS Biol. 2013 Nov;11(11):e1001716. doi: 10.1371/journal.pbio.1001716. Epub 2013 Nov 19.
7
Too few, too weak: conflict of interest policies at Canadian medical schools.太少、太弱：加拿大医学院的利益冲突政策。
PLoS One. 2013 Jul 4;8(7):e68633. doi: 10.1371/journal.pone.0068633. Print 2013.
8
Knowledge of undisclosed corporate authorship ("ghostwriting") reduces the perceived credibility of antidepressant research: a randomized vignette study with experienced nurses.对未披露的企业代笔情况（“捉刀代笔”）的了解会降低对抗抑郁药研究可信度的认知：一项针对经验丰富护士的随机 vignette 研究 。
BMC Res Notes. 2012 Sep 5;5:490. doi: 10.1186/1756-0500-5-490.
9
Conflict of interest reporting by authors involved in promotion of off-label drug use: an analysis of journal disclosures.作者在推广药物超适应证使用中利益冲突的报告：对期刊披露情况的分析。
PLoS Med. 2012;9(8):e1001280. doi: 10.1371/journal.pmed.1001280. Epub 2012 Aug 7.
10
Challenging medical ghostwriting in US courts.在美国法庭上挑战医疗 ghostwriting。
PLoS Med. 2012 Jan;9(1):e1001163. doi: 10.1371/journal.pmed.1001163. Epub 2012 Jan 24.
本文引用的文献
1
Responsible authorship: why researchers must forgo honorary authorship.责任作者制：研究人员为何必须放弃挂名作者。
Account Res. 2011 Mar;18(2):76-90. doi: 10.1080/08989621.2011.557297.
2
Knowledge of ghostwriting and financial conflicts-of-interest reduces the perceived credibility of biomedical research.对代笔行为和经济利益冲突的了解会降低生物医学研究的可信度。
BMC Res Notes. 2011 Jan 31;4:27. doi: 10.1186/1756-0500-4-27.
3
The haunting of medical journals: how ghostwriting sold "HRT".医学期刊的幽灵：代笔如何推销“HRT”。
PLoS Med. 2010 Sep 7;7(9):e1000335. doi: 10.1371/journal.pmed.1000335.
4
The financing of drug trials by pharmaceutical companies and its consequences: part 2: a qualitative, systematic review of the literature on possible influences on authorship, access to trial data, and trial registration and publication.制药公司资助药物试验及其后果：第 2 部分：对可能影响作者身份、试验数据获取以及试验注册和发表的文献进行定性、系统的综述。
Dtsch Arztebl Int. 2010 Apr;107(17):295-301. doi: 10.3238/arztebl.2010.0295. Epub 2010 Apr 30.
5
The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials.制药公司资助药物试验及其后果。第 1 部分：对可能影响药物试验结果、方案和质量的文献进行定性、系统的回顾。
Dtsch Arztebl Int. 2010 Apr;107(16):279-85. doi: 10.3238/arztebl.2010.0279. Epub 2010 Apr 23.
6
Ghostwriting: the dirty little secret of medical publishing that just got bigger.代写论文：医学出版界的肮脏小秘密，现在变得更大了。
PLoS Med. 2009 Sep;6(9):e1000156. doi: 10.1371/journal.pmed.1000156. Epub 2009 Sep 8.
7
Ghosts in the machine: publication planning in the medical sciences.机器中的幽灵：医学科学中的出版规划
Soc Stud Sci. 2009 Apr;39(2):171-98. doi: 10.1177/0306312708101047.
8
What should be done to tackle ghostwriting in the medical literature?应该采取什么措施来应对医学文献中的代笔问题？
PLoS Med. 2009 Feb 3;6(2):e23. doi: 10.1371/journal.pmed.1000023.
9
Industry-sponsored ghostwriting in clinical trial reporting: a case study.临床试验报告中行业资助的代笔行为：一项案例研究。
Account Res. 2008 Jul-Sep;15(3):152-67. doi: 10.1080/08989620802194384.
10
Guest authorship, mortality reporting, and integrity in rofecoxib studies.
JAMA. 2008 Aug 27;300(8):900; author reply 904-6. doi: 10.1001/jama.300.8.900-a.
Zotero 插件